Passage BIO, Inc. (PASG) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	S-1
Revenues	-3.0	-8.0	-1.0	-0.5	-3.4
Revenue growth	-62.5%	700.0%	100.0%	-85.2%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0
Gross profit	-3.0	-8.0	-1.0	-0.5	-3.4
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%
Selling, general and administrative [+]	49.3	60.1	30.1	7.0	0.9
General and administrative	49.3	60.1	30.1	7.0	0.9
Research and development	86.1	117.7	81.8	29.7	9.2
EBITDA [+]	-134.7	-184.2	-112.1	-37.1
EBITDA growth	-26.9%	64.3%	202.5%	175.2%
EBITDA margin	4490.5%	2302.3%	11210.2%	7411.0%	399.5%
Depreciation and amortization	3.7	1.5	0.8	0.1
EBIT [+]	-138.4	-185.7	-112.9	-37.2	-13.5
EBIT growth	-25.5%	64.5%	203.6%	176.2%
EBIT margin	4613.1%	2321.6%	11290.2%	7437.8%	399.5%
Interest income	2.3	0.3	0.7	0.7
Interest income	2.3	0.3	0.7	0.7
Other income (expense), net				-9.1	0.7
Pre-tax income	-136.1	-185.4	-112.2	-45.6	-12.8
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-136.1	-185.4	-112.2	-45.6	-12.8
Net margin	4537.5%	2317.3%	11223.2%	9126.8%	378.8%

Basic EPS [+]	($2.50)	($3.48)	($2.91)	($10.77)	($3.55)
Growth	-28.0%	19.6%	-73.0%	203.5%
Diluted EPS [+]	($2.50)	($3.48)	($2.91)	($10.77)	($3.55)
Growth	-28.0%	19.6%	-73.0%	203.5%

Shares outstanding (basic) [+]	54.4	53.3	38.6	4.2	3.6
Growth	2.0%	38.1%	811.6%	17.7%
Shares outstanding (diluted) [+]	54.4	53.3	38.6	4.2	3.6
Growth	2.0%	38.1%	811.6%	17.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.